1.76 USD
▼-0.03-1.40%
盘后 1.48 0.00%
2026-09-16
市值
$80.72M
市盈率
—
EPS
-1.05
股息率
—
52 周区间
1.15 – 2.28
成交量
330.99K
Beta
-0.68
目标价
8.50
52W 低 1.1552W 高 2.28
价格走势
公司简介
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company’s pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and i...